Accreditation Information

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 13 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Live activity, The Steven J. Parker Memorial Developmental-Behavioral Pediatric Conference: Clinical Problems in Primary Care, with a beginning date of 03/10/2017, has been reviewed and is acceptable for up to 13.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 13 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Contact Hours:  13.5 of which 3 is eligible for pharmacology credit.

Nurses will receive contact hours for those sessions attended, after completion of the evaluation

This program has been approved by the National Association of Pediatric Nurse Practitioners, Inc., (NAPNAP) Continuing Education Committee for the following contact hours: 13.25 contact hours of which 3 contact hours are pharmacology. (Program #A10-17-02)

Needs Statement

Emotional and behavioral problems among children and adolescents continue to be highly prevalent and their significance for well-being is well documented but the vast majority of children…are still unidentified and untreated (Academic Pediatrics, Volume 10, Number 4, July – August 2010 252-259). In addition, children with special health care needs are a population that has received recent focus in attention and need as the medical home and accountable care are both designed to improve care for these complex children.

Early identification of developmental disorders is critical to the well-being of children and their families. It is an integral function of the primary care medical home and an appropriate responsibility of all pediatric health care professionals. Delayed or disordered development can be caused by specific medical conditions and may indicate an increased risk of other medical complications. Delayed or disordered development may also indicate an increased risk of behavior disorders or associated developmental disorders. Early identification should lead to further evaluation, diagnosis, and treatment. Early intervention is available for a wide range of developmental disorders; their prompt identification can spur specific and appropriate therapeutic interventions. Identification of a developmental disorder and its underlying etiology may also affect a range of treatment planning, from medical treatment of the child to family planning for his or her parents. In order to identify a delay, pediatric clinicians need to be aware of what problems exist and how they manifest.

Of nearly 7.4 million children in the United States diagnosed with emotional, behavioral, or developmental conditions, a disproportionate number do not get the mental health services they need because they are under insured, according to a new report released by the Health Resources and Services Administration (HRSA). The study also finds that boys, adolescents, and children from low-income families are affected by conditions such as depression or Attention Deficit Disorder at higher rates than other children, but that adequate health services for these children remain an unmet need. In addition transition issues for these same children are of paramount importance and complexity.

The report, “The Mental and Emotional Well-Being of Children: A Portrait of States and the Nation 2007,” identified seven emotional, behavioral, or developmental conditions: depression, anxiety, Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder, conduct disorders, autism spectrum disorders, developmental delay and Tourette Syndrome. Children with these conditions can benefit from a variety of therapies including counseling and medication.

In addition in the last five years with the mandate of the Affordable Care Act, there has been increased emphasis on the importance of integrated behavioral health. Behavioral health and physical health are inter-related; providing behavioral health care in a primary medical care setting can reduce stigma and discrimination, be cost effective and lead to improved patient outcomes. (http://www.hrsa.gov/publichealth/clinical/BehavioralHealth/index.html)

This year we will have two cutting edge modules to address these issues: one specifically on BHI and a second on risk factors to development.

This conference will address many of these gaps.

Objectives

Through lectures and question and answer sessions, participants at the conclusion of this conference will be able to:

• Describe the latest clinical information on developmental and behavioral issues in children and families
• Identify such problems in their practice and work settings
• Choose and provide appropriate treatment for such issues

 

Target Audience

Primary care physicians, pediatricians, pediatric nurse practitioners, nurses, child mental health professionals, physician assistants and family nurse practitioners.

Faculty Disclosure

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.